
A graded dosing protocol permitted two patients with hypersensitivity reactions to the very first dosage of Moderna’s COVID-19 vaccine to receive their 2nd doses safely, researchers said.
The clients– one with an immediate hypersensitivity response handled on site and one needing emergency department transport– got divided 2nd dosages, reported S. Shahzad Mustafa, MD, of Rochester Regional Health in Rochester, New York City, and associates
3 to 4 weeks after getting the 2nd dosage, both patients had IgG antibodies versus the spike protein of COVID-19, “suggesting vaccination was efficacious regardless of the graded dosing procedure,” they wrote in Annals of Internal Medicine One had no response to the second dose while the other experience some non-serious allergic symptoms.

CDC recommends versus COVID-19 vaccination in people who have immediate allergic reactions to a previous dose of or any element of COVID-19 vaccines. They also advise against a 2nd dosage in individuals with instant hypersensitivity reactions to the very first dosage.
Both of the patients described by Mustafa’s group worked in healthcare. One, a 64- year-old lady, had generalized pruritus, urticaria, and self-reported tachycardia within 10 minutes of the very first dosage of Moderna vaccine.
The 2nd client was a lady, age 39, with chest and neck urticaria within 15 minutes of her very first dosage of the Moderna vaccine, who went on to develop mild facial angioedema within 30 minutes, even after being treated with 25 mg of oral diphenhydramine. She was transported to the emergency situation department and gotten 20 mg of intravenous famotidine and 125 mg of methylprednisolone. She was discharged house following 2 hours of observation and no more signs.
An allergic reaction practice then performed a skin prick and intradermal testing for polyethylene glycol, polysorbate, and the Moderna vaccine. Both patients were positive for the Moderna vaccine, but unfavorable for the other two parts.
Both clients agreed to receive the 2nd dose of vaccine through a graded dosing procedure utilized with other vaccines. The very first client had no symptoms throughout the protocol; the second reported pruritus after doses 2 and 5, which resolved.
The authors worried that their experience reveals that individuals with an immediate hypersensitivity reaction can receive the second dose of Moderna vaccine through a graded dosing protocol, and that consultation with an allergy and immunology specialist for assessment and management may be better suited than instantly delaying their 2nd dosage.
Limitations consisted of that these cases did not include patients experiencing anaphylaxis after the very first dosage of Moderna vaccine, and more research study is required to figure out if one dosage is sufficient in these clients.
-
< img alt="author['full_name']
" src="https://clf1.medpagetoday.com/media/images/author/mollyWalker_188 jpg" >Molly Walker is an associate editor, who covers transmittable diseases for MedPage Today. She has a passion for evidence, data and public health. Follow
.
Disclosures
Mustafa disclosed no appropriate relationships with market.
No comments:
Post a Comment